Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pol Specenier

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Expert Review of Anticancer Therapy|November 28, 2012
Ipilimumab in melanomaPol Specenier
Expert Review of Anticancer Therapy|December 14, 2011
Bevacizumab in glioblastoma multiformePol Specenier
Expert Review of Pharmacoeconomics & Outcomes Research|November 23, 2020
Cost-effectiveness of nivolumab in advanced melanoma: a drug reviewPol Specenier
Expert Review of Anticancer Therapy|November 8, 2016
Nivolumab in melanomaPol Specenier
Current Opinion in Otolaryngology & Head and Neck Surgery|February 19, 2021
Immunotherapy for head and neck cancer: from recurrent/metastatic disease to (neo)adjuvant treatment in surgically resectable tumorsPol Specenier
Expert Opinion on Pharmacotherapy|January 29, 2019
Efficacy of nab-paclitaxel in treating metastatic melanomaPol Specenier
Expert Review of Anticancer Therapy|March 22, 2018
Nivolumab in squamous cell carcinoma of the head and neckPol Specenier
Expert Opinion on Pharmacotherapy|February 27, 2020
An overview of binimetinib for the treatment of melanomaPol Specenier
Expert Review of Anticancer Therapy|July 13, 2016
Ipilimumab in melanomaPol Specenier
Expert Opinion on Biological Therapy|March 22, 2017
Pembrolizumab use for the treatment of advanced melanomaPol Specenier
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Expert Review of Anticancer Therapy|November 28, 2012
Ipilimumab in melanomaPol Specenier
Expert Review of Anticancer Therapy|December 14, 2011
Bevacizumab in glioblastoma multiformePol Specenier
Expert Review of Pharmacoeconomics & Outcomes Research|November 23, 2020
Cost-effectiveness of nivolumab in advanced melanoma: a drug reviewPol Specenier
Expert Review of Anticancer Therapy|November 8, 2016
Nivolumab in melanomaPol Specenier
Current Opinion in Otolaryngology & Head and Neck Surgery|February 19, 2021
Immunotherapy for head and neck cancer: from recurrent/metastatic disease to (neo)adjuvant treatment in surgically resectable tumorsPol Specenier
Expert Opinion on Pharmacotherapy|January 29, 2019
Efficacy of nab-paclitaxel in treating metastatic melanomaPol Specenier
Expert Review of Anticancer Therapy|March 22, 2018
Nivolumab in squamous cell carcinoma of the head and neckPol Specenier
Expert Opinion on Pharmacotherapy|February 27, 2020
An overview of binimetinib for the treatment of melanomaPol Specenier
Expert Review of Anticancer Therapy|July 13, 2016
Ipilimumab in melanomaPol Specenier
Expert Opinion on Biological Therapy|March 22, 2017
Pembrolizumab use for the treatment of advanced melanomaPol Specenier
Pageof 6